Manhattan Bridge Capital (LOAN) Prices 1.875M Share Offering at $7.20/sh

Go back to Manhattan Bridge Capital (LOAN) Prices 1.875M Share Offering at $7.20/sh

After-Hours Stock Movers 07/06: (OPNT) (IMMR) (CFMS) Higher; (IDYA) (LOAN) (EFC) Lower (more...)

July 6, 2021 6:03 PM EDT

After-Hours Stock Movers:

Opiant Pharmaceuticals, Inc.(NASDAQ: OPNT) 51.7% HIGHER; Announced positive top-line results from its confirmatory pharmacokinetic study for OPNT003, nasal nalmefene, for opioid overdose.

IDEAYA Biosciences, Inc. (Nasdaq: IDYA) 10.9% LOWER; announced that it intends to offer and sell up to $80 million of shares of its... More

Manhattan Bridge Capital (LOAN) Announces Proposed Share Offering; Size not Disclosed

July 6, 2021 4:05 PM EDT

Manhattan Bridge Capital, Inc. (NasdaqCM: LOAN), or Manhattan Bridge Capital, a real estate finance company specializing in originating, funding, servicing, and managing a portfolio of short-term loans secured by first mortgage liens on real estate, announced today that it is proposing to offer its common shares, par value $0.001 per share, in an underwritten public offering. Manhattan Bridge Capital expects to grant the underwriter a 30-day option to purchase up to an additional 15 percent of its common shares offered in the public offering, at the same public offering price per share, less underwriting discounts and... More

Manhattan Bridge Capital (LOAN) Announces Proposed Share Offering; Size not Disclosed

July 6, 2021 4:05 PM EDT

Manhattan Bridge Capital, Inc. (NasdaqCM: LOAN), or Manhattan Bridge Capital, a real estate finance company specializing in originating, funding, servicing, and managing a portfolio of short-term loans secured by first mortgage liens on real estate, announced today that it is proposing to offer its common shares, par value $0.001 per share, in an underwritten public offering. Manhattan Bridge Capital expects to grant the underwriter a 30-day option to purchase up to an additional 15 percent of its common shares offered in the public offering, at the same public offering price per share, less underwriting discounts and... More